91 related articles for article (PubMed ID: 16690844)
1. Comment on "Evidence for positive epistasis in HIV-1".
Wang K; Mittler JE; Samudrala R
Science; 2006 May; 312(5775):848; author reply 848. PubMed ID: 16690844
[TBL] [Abstract][Full Text] [Related]
2. Evidence for positive epistasis in HIV-1.
Bonhoeffer S; Chappey C; Parkin NT; Whitcomb JM; Petropoulos CJ
Science; 2004 Nov; 306(5701):1547-50. PubMed ID: 15567861
[TBL] [Abstract][Full Text] [Related]
3. Evolution. Epistasis in RNA viruses.
Michalakis Y; Roze D
Science; 2004 Nov; 306(5701):1492-3. PubMed ID: 15567846
[No Abstract] [Full Text] [Related]
4. Evaluation of Viroseq-HIV version 2 for HIV drug resistance.
Mukaide M; Sugiura W; Matuda M; Usuku S; Noguchi Y; Suzuki K; Kawata K; Ito A; Sagara H; Yamada K; Kondo M; Imai M
Jpn J Infect Dis; 2000 Oct; 53(5):203-5. PubMed ID: 11135705
[No Abstract] [Full Text] [Related]
5. Your next nightmare: 28% of new HIV cases may be drug-resistant.
AIDS Alert; 1999 Dec; 14(12):133-7. PubMed ID: 11366987
[TBL] [Abstract][Full Text] [Related]
6. Epistasis and Pleiotropy Affect the Modularity of the Genotype-Phenotype Map of Cross-Resistance in HIV-1.
Polster R; Petropoulos CJ; Bonhoeffer S; Guillaume F
Mol Biol Evol; 2016 Dec; 33(12):3213-3225. PubMed ID: 27678053
[TBL] [Abstract][Full Text] [Related]
7. Interpretation of resistance assay results.
Miller V
Antivir Ther; 2001; 6 Suppl 2():1-9. PubMed ID: 11678473
[No Abstract] [Full Text] [Related]
8. Limits to detecting epistasis in the fitness landscape of HIV.
Biswas A; Haldane A; Levy RM
PLoS One; 2022; 17(1):e0262314. PubMed ID: 35041711
[TBL] [Abstract][Full Text] [Related]
9. Detection and significance of minority quasispecies of drug-resistant HIV-1.
Metzner KJ
J HIV Ther; 2006 Dec; 11(4):74-81. PubMed ID: 17578210
[No Abstract] [Full Text] [Related]
10. Prediction of HIV-1 drug susceptibility phenotype from the viral genotype using linear regression modeling.
Vermeiren H; Van Craenenbroeck E; Alen P; Bacheler L; Picchio G; Lecocq P;
J Virol Methods; 2007 Oct; 145(1):47-55. PubMed ID: 17574687
[TBL] [Abstract][Full Text] [Related]
11. Genetic Consequences of Antiviral Therapy on HIV-1.
Arenas M
Comput Math Methods Med; 2015; 2015():395826. PubMed ID: 26170895
[TBL] [Abstract][Full Text] [Related]
12. Advances in understanding the evolution of HIV.
Crandall KA; Vasco DA; Posada D; Imamichi H
AIDS; 1999; 13 Suppl A():S39-47. PubMed ID: 10885761
[No Abstract] [Full Text] [Related]
13. Overview on HIV-1-related drug resistance: from theory to clinical practice.
Moroni M; Balotta C; Rusconi S
J Biol Regul Homeost Agents; 1998; 12(1-2 Suppl):15-8. PubMed ID: 9689573
[No Abstract] [Full Text] [Related]
14. Revisiting the concept of a genetic barrier to resistance.
Rusconi S
J HIV Ther; 2006 Dec; 11(4):81-3. PubMed ID: 17578211
[No Abstract] [Full Text] [Related]
15. HIV-1 group O resistance pathway with raltegravir is similar to HIV-1 group M.
Alessandri-Gradt E; Morgand M; Delaugerre C; Peytavin G; Sellier P; Simon F; Plantier JC
AIDS; 2015 Jun; 29(10):1271-3. PubMed ID: 26035328
[No Abstract] [Full Text] [Related]
16. New data brings resistance testing closer to routine clinical use.
Murphy MJ
Fac Notes (New Orleans La); 1999; 11(3):6. PubMed ID: 11810872
[No Abstract] [Full Text] [Related]
17. Rationale and uses of a public HIV drug-resistance database.
Shafer RW
J Infect Dis; 2006 Sep; 194 Suppl 1(Suppl 1):S51-8. PubMed ID: 16921473
[TBL] [Abstract][Full Text] [Related]
18. Transmission of drug-resistant strains of HIV-1: unfortunate, but inevitable.
Cohen OJ; Fauci AS
Lancet; 1999 Aug; 354(9180):697-8. PubMed ID: 10475176
[No Abstract] [Full Text] [Related]
19. High levels of primary antiretroviral resistance genotypic mutations and B/F recombinants in Santos, Brazil.
Sucupira MC; Caseiro MM; Alves K; Tescarollo G; Janini LM; Sabino EC; Castelo A; Page-Shafer K; Diaz RS
AIDS Patient Care STDS; 2007 Feb; 21(2):116-28. PubMed ID: 17328661
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of drug resistance-related mutations among HIV-1s in Japan.
Sugiura W; Matsuda M; Abumi H; Yamada K; Taki M; Ishikawa M; Miura T; Fukutake K; Gouchi K; Ajisawa A; Iwamoto A; Hanabusa H; Mimaya J; Takamatsu J; Takada N; Kakishita E; Yoshioka A; Kashiwagi S; Shirahata A; Nagai Y
Jpn J Infect Dis; 1999 Feb; 52(1):21-2. PubMed ID: 10808258
[No Abstract] [Full Text] [Related]
[Next] [New Search]
